ME01066B - Upotreba oksikodona za tretiranje visceralnog bola - Google Patents

Upotreba oksikodona za tretiranje visceralnog bola

Info

Publication number
ME01066B
ME01066B MEP-2009-352A MEP35209A ME01066B ME 01066 B ME01066 B ME 01066B ME P35209 A MEP35209 A ME P35209A ME 01066 B ME01066 B ME 01066B
Authority
ME
Montenegro
Prior art keywords
oxycodone
visceral pain
treating visceral
treating
pain
Prior art date
Application number
MEP-2009-352A
Other languages
English (en)
French (fr)
Inventor
Asbjorn Mohr Drewes
Lars Arendt Nielsen
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35871217&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME01066(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of ME01066B publication Critical patent/ME01066B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
MEP-2009-352A 2005-01-18 2006-01-17 Upotreba oksikodona za tretiranje visceralnog bola ME01066B (me)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64549005P 2005-01-18 2005-01-18
PCT/EP2006/050252 WO2006077212A1 (en) 2005-01-18 2006-01-17 Use of oxycodone for treating visceral pain
EP06700652A EP1838318B1 (en) 2005-01-18 2006-01-17 Use of oxycodone for treating visceral pain

Publications (1)

Publication Number Publication Date
ME01066B true ME01066B (me) 2012-10-20

Family

ID=35871217

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2009-352A ME01066B (me) 2005-01-18 2006-01-17 Upotreba oksikodona za tretiranje visceralnog bola

Country Status (32)

Country Link
US (2) US20080200493A1 (me)
EP (1) EP1838318B1 (me)
JP (1) JP5049139B2 (me)
KR (10) KR20080106991A (me)
CN (1) CN101106996B (me)
AP (1) AP2249A (me)
AR (1) AR052880A1 (me)
AT (2) ATE446092T1 (me)
AU (1) AU2006207498B2 (me)
BR (1) BRPI0606247A2 (me)
CA (1) CA2595043C (me)
CY (1) CY1109660T1 (me)
DE (2) DE602006009899D1 (me)
DK (2) DK1838318T3 (me)
EA (1) EA013544B1 (me)
ES (1) ES2333901T3 (me)
HK (1) HK1107933A1 (me)
HR (1) HRP20090679T1 (me)
IL (1) IL184530A (me)
ME (1) ME01066B (me)
MX (1) MX2007007207A (me)
MY (1) MY144471A (me)
NO (1) NO338968B1 (me)
NZ (1) NZ555852A (me)
PL (1) PL1838318T3 (me)
PT (1) PT1838318E (me)
RS (1) RS51069B (me)
SI (1) SI1838318T1 (me)
TW (1) TWI432196B (me)
UA (1) UA85471C2 (me)
WO (1) WO2006077212A1 (me)
ZA (1) ZA200705231B (me)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2380592T3 (en) 2005-11-14 2018-03-19 Teva Pharmaceuticals Int Gmbh Antagonist antibody directed to calcitonin gene related peptide
WO2008148798A2 (en) 2007-06-04 2008-12-11 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
CN107296957A (zh) 2008-03-04 2017-10-27 梯瓦制药国际有限责任公司 治疗慢性疼痛的方法
EP2393484A1 (en) 2009-02-06 2011-12-14 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
CA2766179A1 (en) 2009-06-24 2010-12-29 Egalet Ltd. Controlled release formulations
KR101519192B1 (ko) * 2009-08-28 2015-05-11 리나트 뉴로사이언스 코프. 칼시토닌 유전자-관련된 펩티드에 대해 지시된 길항제 항체의 투여에 의한 내장 통증의 치료 방법
EP2709663B1 (en) 2011-05-20 2019-03-20 AlderBio Holdings LLC Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
EA039905B1 (ru) 2011-05-20 2022-03-25 Х. Лундбек А/С Анти-cgrp антитела и их применение
BR112013029951B1 (pt) 2011-05-20 2020-10-20 Alderbio Holdings Llc composição farmacêutica e uso de anticorpos ou fragmentos de anticorpos anti-cgrp para tratar ou prevenir formas de diarreia crônicas e agudas
US10556945B2 (en) 2014-03-21 2020-02-11 Teva Pharmaceuticals International Gmbh Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
CA2943551A1 (en) 2014-03-21 2015-09-24 Teva Pharmaceuticals International Gmbh Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
BR112019005823A2 (pt) 2016-09-23 2019-06-25 Teva Pharmaceuticals Int Gmbh tratamento para enxaqueca refratária
US11400052B2 (en) 2018-11-19 2022-08-02 Jazz Pharmaceuticals Ireland Limited Alcohol-resistant drug formulations
EP3908606A4 (en) 2019-01-08 2022-11-23 H. Lundbeck A/S ACUTE AND RAPID TREATMENT OF HEADACHES USING ANTI-CGRP ANTIBODIES

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656295A (en) * 1991-11-27 1997-08-12 Euro-Celtique, S.A. Controlled release oxycodone compositions
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
EA000976B1 (ru) * 1996-03-25 2000-08-28 Эли Лилли Энд Компани Композиция для снятия боли и способ снятия боли
UA81224C2 (uk) * 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
US6992193B2 (en) * 2003-06-10 2006-01-31 Adolor Corporation Sulfonylamino phenylacetamide derivatives and methods of their use

Also Published As

Publication number Publication date
NO338968B1 (no) 2016-11-07
WO2006077212A1 (en) 2006-07-27
DK200700207U3 (da) 2007-09-28
HK1107933A1 (en) 2008-04-25
KR20230170811A (ko) 2023-12-19
KR20120089710A (ko) 2012-08-13
US9271974B2 (en) 2016-03-01
CN101106996B (zh) 2013-10-23
AP2249A (en) 2011-07-18
SI1838318T1 (sl) 2010-02-26
EP1838318B1 (en) 2009-10-21
MY144471A (en) 2011-09-30
KR20070100368A (ko) 2007-10-10
IL184530A (en) 2015-01-29
JP5049139B2 (ja) 2012-10-17
CA2595043A1 (en) 2006-07-27
IL184530A0 (en) 2007-10-31
TW200637554A (en) 2006-11-01
NO20074174L (no) 2007-10-17
EA200701541A1 (ru) 2008-02-28
US20150190393A1 (en) 2015-07-09
US20080200493A1 (en) 2008-08-21
DK1838318T3 (da) 2010-01-04
UA85471C2 (ru) 2009-01-26
AP2007004057A0 (en) 2007-08-31
DK200700207U1 (da) 2007-08-24
EA013544B1 (ru) 2010-06-30
HRP20090679T1 (hr) 2010-01-31
EP1838318A1 (en) 2007-10-03
AU2006207498A1 (en) 2006-07-27
NZ555852A (en) 2010-01-29
BRPI0606247A2 (pt) 2009-06-09
RS51069B (sr) 2010-10-31
ES2333901T3 (es) 2010-03-02
DE602006009899D1 (de) 2009-12-03
CA2595043C (en) 2013-11-19
PL1838318T3 (pl) 2010-03-31
AT9895U1 (de) 2008-05-15
TWI432196B (zh) 2014-04-01
KR20210131450A (ko) 2021-11-02
CN101106996A (zh) 2008-01-16
JP2008526927A (ja) 2008-07-24
AR052880A1 (es) 2007-04-11
KR20080106991A (ko) 2008-12-09
CY1109660T1 (el) 2014-08-13
KR20220165797A (ko) 2022-12-15
PT1838318E (pt) 2009-12-15
KR20140091782A (ko) 2014-07-22
DE202006019887U1 (de) 2007-07-26
ATE446092T1 (de) 2009-11-15
KR20190135557A (ko) 2019-12-06
KR20200128451A (ko) 2020-11-12
KR20170021905A (ko) 2017-02-28
MX2007007207A (es) 2007-08-15
ZA200705231B (en) 2008-06-25
AU2006207498B2 (en) 2009-11-19

Similar Documents

Publication Publication Date Title
IL184530A0 (en) Use of oxycodone for treating visceral pain
ZA200801253B (en) Novel use of peptide compounds for treating muscle pain
IL248204A0 (en) Combined treatment of tumors expressing 38cd
GB0610867D0 (en) Treatment of pain
IL193748A0 (en) Treatment of pain
PL1951273T3 (pl) Zastosowanie lactobacillus do leczenia chorób autoimmunologicznych
IL188430A0 (en) Treatment of tumors
IL193460A0 (en) Compounds and methods for treatment of stroke
EP1838714A4 (en) METHODS OF TREATING PAIN
EP2049139A4 (en) TREATMENT OF TUMORS EXPRESSING RAS
EP1928452A4 (en) USE OF SODIUM CHANNEL BLOCKS FOR THE TREATMENT OF VISCERAL PAIN OR PAIN THROUGH CANCER TREATMENT
IL201422A0 (en) Therapeutic agents useful for treating pain
EP1968591A4 (en) TREATMENT OF SYNUCLEINOPATHIES
ZA200802935B (en) Use of lactobacillus for treatment of autoimmune diseases
EP1867640A4 (en) MEANS FOR TREATING SOLID TUMORS
EP2007790A4 (en) COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
GB0610868D0 (en) Treatment of pain
ZA200904478B (en) Novel therapeutic use for treating leukaemia
IL188894A0 (en) Compounds for treatment of lipase-mediated diseases
EP1813271A4 (en) PREVENTIVE / THERAPEUTIC AGENT FOR VISCERAL PAIN
GB0616450D0 (en) Treatment of pain
GB0623740D0 (en) Treatment of disease
EP1878443A4 (en) THERAPEUTIC AGENT FOR NEUROPATHIC PAIN
GB0408521D0 (en) Treatment of sepsis